Can I take finasteride and dutasteride together for androgenic alopecia (hair loss)?

Taking Finasteride and Dutasteride Together for Hair Loss

Do not combine finasteride and dutasteride for androgenetic alopecia—use dutasteride monotherapy instead, as it is more potent and provides superior hair regrowth compared to finasteride alone.

Rationale Against Combination Therapy

The available evidence does not support combining these medications because:

• Dutasteride is already superior to finasteride as monotherapy 1, 2, 3. Dutasteride 0.5 mg daily significantly increases hair count and width more than finasteride 1 mg daily, with one study showing dutasteride increased hair count by 246 hairs/cm² versus finasteride's 231 hairs/cm² at 24 weeks 1.

• Both drugs work through the same mechanism—inhibiting 5-alpha-reductase to reduce dihydrotestosterone (DHT) 4, 5. Finasteride inhibits only type II 5-alpha-reductase (reducing serum DHT by ~70%), while dutasteride inhibits both type I and type II isoenzymes (reducing serum DHT by ~95%) 4, 5.

• Adding finasteride to dutasteride provides no additional benefit since dutasteride already achieves near-maximal DHT suppression 5. The pharmacologic ceiling effect means further DHT reduction is negligible.

Evidence for Dutasteride Monotherapy

Dutasteride demonstrates dose-dependent efficacy superior to finasteride:

• At 24 weeks, dutasteride 0.5 mg showed significantly greater hair count increases in a 2.54-cm diameter area compared to finasteride 1 mg (P = 0.003) 2.

• Dutasteride produced significantly greater reversal of hair miniaturization (baseline 65 thin hairs/cm² to 57 at 24 weeks) versus finasteride (67 to 66 thin hairs/cm²) 1.

• A systematic review confirmed dutasteride is more potent than finasteride in treating androgenetic alopecia in both males and females 3.

The Single Exception: Finasteride Non-Responders

The only scenario where adding dutasteride to existing finasteride therapy may be considered is in patients who have been on finasteride for ≥6 months without adequate response 6, 7:

• One case report showed a 47-year-old man on finasteride for 4 years who experienced declining hair density had dramatic improvement when low-dose dutasteride 0.5 mg weekly was added 6.

• A study of 35 Korean men with inadequate finasteride response found that switching to dutasteride 0.5 mg daily resulted in 77.4% showing improvement, with hair density increasing by 10.3% and thickness by 18.9% 7.

However, the preferred approach is switching to dutasteride monotherapy rather than combination therapy 7, 8.

Safety Profile

Both medications have comparable adverse event profiles 1, 2, 3:

• Sexual dysfunction (erectile dysfunction, decreased libido, ejaculatory dysfunction) occurs in 2-4% more patients than placebo 4.
• Gynecomastia is reported in both groups 4.
• Sexual side effects are reversible and decrease over time 4.
• No significant difference in discontinuation rates between finasteride and dutasteride 1, 2.

Combining both medications would theoretically increase the risk of adverse events without providing additional efficacy benefit.

Practical Recommendations

For treatment-naive patients:

• Start with dutasteride 0.5 mg daily as first-line therapy 8, 2, 3.
• Alternative: Dutasteride 0.5 mg three times weekly showed comparable efficacy to finasteride 1 mg daily with similar safety 9.

For patients currently on finasteride with inadequate response after 6 months:

• Switch to dutasteride 0.5 mg daily (not combination therapy) 7, 8.
• Expect to see results within 12-24 weeks 1, 2.

Important monitoring considerations:

• Both medications reduce PSA levels by approximately 50% after 12 months; double the measured PSA value when screening for prostate cancer 4.
• Dutasteride has a much longer half-life (5 weeks) compared to finasteride (4.5 hours), meaning it takes longer to clear from the system 8.